Large Cap Swiss companies >$10 bn, listed on US exchanges, NYSE, NASDAQ or OTC are in most - but not all - cases, actively traded
Noteworthy exceptions, mostly ignored by U.S. investors, include chemical industry majors - $27bn DSM-Firmenich
The companion theme is "MidCap U.S. listings" with capitalizations in the range of $2 bn to $10 bn
When loosely traded on OTC markets, their performance will usually reflect the trend but not the actual performance on their home market, adjusted for currency shifts - their track record on OTC is strictly informative and might justify further research - Check Swiss exchanges for actual performance !
With low trading volume on U.S. OTC markets for the listed shares, performance, volatility and drawdown calculations will be affected - these ratios do not reflect true performance, volatility and drawdown as these same shares are normally traded on their national exchange
Our platform of asset information will include fundamental data information for companies listed on NYSE and NASDAQ, but accounting data for the OTC (over-the-counter) quoted firms is not available
To highlight momentum and check trends, selected a short time frame - from two weeks to six months - on the menu (top right)
Investors are free to bookmark stocks of interest and to test investments in their virtual portfolio